Sphenopalatine Ganglion Nerve Block for the Treatment of Migraine Headaches in the Pediatric Population

被引:1
|
作者
Mousa, Mohammad A. [1 ]
Aria, David J. [1 ,2 ]
Mousa, Abeer A. [1 ]
Schaefer, Carrie M. [1 ,2 ]
Temkit, M. Hamed H. [3 ]
Towbin, Richard B. [1 ,2 ]
机构
[1] Univ Arizona, Coll Med Phoenix, 475 N 5th St, Phoenix, AZ 85004 USA
[2] Phoenix Childrens Hosp, Dept Radiol, Div Intervent Radiol, Phoenix, AZ USA
[3] Phoenix Childrens Hosp, Clin Res, Phoenix, AZ USA
关键词
Chronic; migraine; minimally invasive; nerve block; pediatric; sphenopalatine; PREVALENCE; ADOLESCENTS; CHILDREN;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Persistent headaches and migraines are common in pediatrics with various treatment options. The sphenopalatine ganglion (SPG) has been identified as communicating with the parasympathetic autonomic nervous system and pain receptors. In adults, SPG block is an established treatment but there is no published literature in pediatrics. Objectives: The purpose of this study is to analyze the SPG block in pediatrics. Study Design: Retrospective, single-center study. Setting: This study was conducted at Phoenix Children's Hospital in Phoenix, Arizona. Methods: A comprehensive review of patient charts from 2015-2018 of all pediatric SPG blockades performed by interventional radiology were included in the analysis. Utilizing fluoroscopic guidance, a SphenoCath was inserted into each nostril and after confirming position, and 4% lidocaine injected. Pre- and postprocedural pain was assessed using the Visual Analog Scale (VAS). Immediate and acute complications were documented. Results: A total of 489 SPG blocks were performed in patients between ages 6 and 26 years who were diagnosed with migraine or status migrainosus. One hundred percent technical success was achieved with mean reduction of pain scores of 2.4, which was statistically significant (P < 0.0001). There were no immediate or acute complications. Limitations: Results of this study were based on retrospective study. The use of VAS may be subjective, and the need of a prospective study may be necessary. Conclusions: With 100% technical success, statistically significant pain reduction, and no complications, we support SPG block in the pediatric population as a simple, efficacious, and safe treatment option for refractory headaches. It is routinely performed in less than 10 minutes and commonly negates the need for inpatient headache pain management. Given its minimal invasivity, we support the use of SPG blockade as a therapeutic treatment in refractory pediatric migraines as it reduces the need for intravenous medications, prolonged pain control, or hospital admission.
引用
收藏
页码:E111 / E116
页数:6
相关论文
共 50 条
  • [11] Sphenopalatine Ganglion Block: Treatment of Migraine and Trigeminal Neuralgia Associated With Multiple Sclerosis
    Nagib, Michael
    Hood, Preston
    Matteo, Jerry
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [12] Sphenopalatine ganglion (SPG) block for symptomatic relief of acute migraine
    Jaconelli, Tom
    Crane, Steven
    EMERGENCY MEDICINE JOURNAL, 2024, 41 (10) : 635 - 636
  • [13] Sphenopalatine Ganglion Nerve Blocks for the Management of Acute Migraine Exacerbations
    Shah, A.
    Olinde, A.
    Tay, E.
    ANNALS OF EMERGENCY MEDICINE, 2024, 84 (04) : S38 - S38
  • [14] Electrical Stimulation of Sphenopalatine Ganglion for Acute Treatment of Cluster Headaches
    Ansarinia, Mehdi
    Rezai, Ali
    Tepper, Stewart J.
    Steiner, Charles P.
    Stump, Jenna
    Stanton-Hicks, Michael
    Machado, Andre
    Narouze, Samer
    HEADACHE, 2010, 50 (07): : 1164 - 1174
  • [15] Sphenopalatine Ganglion Block in the Management of Chronic Headaches (vol 21, 27, 2017)
    Mojica, Jeffrey
    Mo, Bi
    Ng, Andrew
    CURRENT PAIN AND HEADACHE REPORTS, 2017, 21 (12) : 1 - 1
  • [16] Sphenopalatine ganglion block in primary headaches An American Headache Society member survey
    Burkett, John G.
    Robbins, Matthew S.
    Robertson, Carrie E.
    Mete, Mihriye
    Saikali, Nicolas P.
    Halker Singh, Rashmi B.
    Ailani, Jessica
    NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (06) : 503 - 509
  • [17] Sphenopalatine ganglion block with topical application of 4% lignocaine in the management of migraine
    Gulotta, G
    Sansone, A
    Savola, G
    Mularo, A
    Piazza, F
    Alongi, A
    Sparacia, B
    BRITISH JOURNAL OF ANAESTHESIA, 1996, 76 : A407 - A407
  • [18] The efficacy of sphenopalatine ganglion block for the treatment of postdural puncture headache among obstetric population
    Albaqami, Mohammed S.
    Alwarhi, Faris, I
    Alqarni, Adel A.
    SAUDI JOURNAL OF ANAESTHESIA, 2022, 16 (01) : 45 - 51
  • [19] Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation
    Puledda, Francesca
    Goadsby, Peter J.
    CURRENT PAIN AND HEADACHE REPORTS, 2016, 20 (07)
  • [20] Acute Treatment of Intractable Migraine With Sphenopalatine Ganglion Electrical Stimulation
    Tepper, Stewart J.
    Rezai, Ali
    Narouze, Samer
    Steiner, Charles
    Mohajer, Pouya
    Ansarinia, Mehdi
    HEADACHE, 2009, 49 (07): : 983 - 989